Time to rethink how we diagnose Alzheimer's disease

October 3, 2018, The North American Menopause Society
PET scan of a human brain with Alzheimer's disease. Credit: public domain

With all the focus on Alzheimer disease in recent years as a result of the aging population, what have we learned? A symposium at The North American Menopause Society (NAMS) Annual Meeting in San Diego, October 3-6, will not only review conflicting evidence regarding the best way to diagnose the disease, but also the latest thinking on the neurodegeneration that often begins during the menopause transition.

The criteria for the diagnosis of dementia due to Alzheimer disease was last updated in 2010. Today, biomarkers (a measurable indicator of the severity or presence of some disease) are often used to help understand the phases of dementia in conjunction with neuropsychological assessments.

Dr. Pauline Maki, a professor of psychiatry, psychology and obstetrics and gynecology, will moderate the symposium at the NAMS 2018 Annual Meeting titled "A Scientific Update on Alzheimer Disease and Women." In addition to summarizing preferred criteria for diagnosing the disease, the symposium will include especially valuable insights for postmenopausal women who, compared to men, are more likely to develop Alzheimer disease during the remainder of their lifetime. It will additionally summarize an impressive body of animal and human research that shows that brain metabolism changes in women after menopause in such a way that it might make them more vulnerable to Alzheimer disease.

"For decades scientists have focused on the amyloid hypothesis of Alzheimer disease, but clinical trials based on that hypothesis have unfortunately failed. There is a new understanding of why biomarkers are important and how they evolve during the course of Alzheimer disease. Scientists are now trying to prevent Alzheimer disease before the memory symptoms appear and are using biomarkers to determine who needs early prevention," says Dr. Maki. "Understanding biomarkers in Alzheimer disease is important because there is roughly a 20-year separation between and Alzheimer, during which time these biomarkers can indicate which women should be targeted for prevention."

"Although Alzheimer is becoming more prevalent as a result of people living longer, it is of particular concern to postmenopausal who, compared to men, are more likely to be affected," says Dr. JoAnn Pinkerton, NAMS executive director. "We look forward to hearing the latest scientific evidence on this critical topic."

Explore further: Why alzheimer's may be tougher to spot in women

Related Stories

Why alzheimer's may be tougher to spot in women

July 23, 2018
(HealthDay)—If your memory starts slipping, your gender may play a role in whether or not you are diagnosed with Alzheimer's disease, a new study suggests. How?

Sex matters: Addressing the Alzheimer's disease research gap

June 12, 2018
To prevent and treat Alzheimer's disease, scientists need to better understand how the disease differs between women and men, according to a paper published June 12 in Alzheimer's & Dementia: The Journal of the Alzheimer's ...

Menopause linked to changes in brain energy use

October 13, 2017
Researchers from Weill Cornell Medicine and the University of Arizona Health Sciences have found that women's brains use less energy during the menopause. The reduction in energy use by the brain was found to be similar to ...

Alzheimer's patients are more often hospitalized after initiating antibiotic use

September 18, 2018
People with Alzheimer's disease (AD) are more often hospitalized after antibiotic initiation than people without AD, a new study from the University of Eastern Finland shows. The risk of hospitalization was 40 per cent higher ...

Study predicts most people with earliest Alzheimer's signs won't develop dementia associated with the disease

May 22, 2018
During the past decade, researchers have identified new ways to detect the earliest biological signs of Alzheimer's disease. These early signs, which are detected by biomarkers, may be present before a person starts to exhibit ...

Model estimates lifetime risk of Alzheimer's dementia using biomarkers

May 22, 2018
Lifetime risks of developing Alzheimer's disease dementia vary considerably by age, gender and whether any signs or symptoms of dementia are present, according to a new study published online by Alzheimer's & Dementia.

Recommended for you

Hypothesis underpinning dementia research 'flawed'

October 16, 2018
A hypothesis which has been the standard way of explaining how the body develops Alzheimer's Disease for almost 30 years is flawed, according to a University of Manchester biologist.

Many cases of dementia may arise from non-inherited DNA 'spelling mistakes'

October 15, 2018
Only a small proportion of cases of dementia are thought to be inherited—the cause of the vast majority is unknown. Now, in a study published today in the journal Nature Communications, a team of scientists led by researchers ...

Scientists create new map of brain region linked to Alzheimer's disease

October 8, 2018
Curing some of the most vexing diseases first requires navigating the world's most complex structure—the human brain. So, USC scientists have created the most detailed atlas yet of the brain's memory bank.

Previously unknown genetic aberrations found to be associated with Alzheimer's progression

October 8, 2018
In a large-scale analysis of RNA from postmortem human brain tissue, researchers at the Icahn School of Medicine at Mount Sinai and Columbia University have identified specific RNA splicing events associated with Alzheimer's ...

Periodontal disease bacteria may kick-start Alzheimer's

October 4, 2018
Long-term exposure to periodontal disease bacteria causes inflammation and degeneration of brain neurons in mice that is similar to the effects of Alzheimer's disease in humans, according to a new study from researchers at ...

AI could predict cognitive decline leading to Alzheimer's disease in the next five years

October 4, 2018
A team of scientists has successfully trained a new artificial intelligence (AI) algorithm to make accurate predictions regarding cognitive decline leading to Alzheimer's disease.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.